More on EVO
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.53 |
|
|||
| Open | $1.54 | ||||
| 52 Wk High | $16.39 | ||||
| 52 Wk Low | $13.22 | ||||
| Day High | $1.56 | ||||
| Day Low | $1.52 | ||||
| P/E | N/A | ||||
| EPS | $-1.61 | ||||
| Volume | 20,622 | ||||
- Form 6-K Evotec SE For: Aug 13
- Evotec and Odyssey partner on autoimmune drug discovery
- Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
- Niagen Bioscience taps Evotec for NB4168 preclinical drug studies
- Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
- Evotec selects Navan to manage travel and expense globally
- Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management
- Evotec AG (EVT:GR) (EVO) PT Lowered to EUR3.50 at Deutsche Bank
- Berenberg Downgrades Evotec AG (EVT:GR) (EVO) to Hold
- Evotec (EVO) PT Lowered to $4 at H.C. Wainwright
Entities mentioned with EVO
- Twitter | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Dividend | View Related Stories »
- EIM Group | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Show More...
